The Feasibility of TACE Combined with TKIs Plus PD-1 Antibody for Advanced HCC.
Tao SunYanqiao RenBo SunLei ChenLicheng ZhuLijie ZhangChuangsheng ZhengPublished in: Journal of hepatocellular carcinoma (2023)
In patients with advanced HCC, TACE-TKIs-C may improve overall and progression-free survival outcomes over TACE-TKIs with manageable safety profile.
Keyphrases